Skin Diseases and Conditions

KDL is committed to partnering with patients and healthcare providers in the prevention, early detection and treatment of cancer and other skin diseases. KDL physicians provide continuing education seminars to healthcare providers to keep them informed of the latest diagnostic tools and information available for their patients.

[All links open in a new browser window.]

KDL Literature on Skin Disease:
Skin Cancer Fact Sheet
Melanoma is on the Rise, Know the Facts

Patient Advocacy Groups & Disease Information:
This section includes downloads and links to educational materials that can patients understand procedures and other related basic information about dermatology, dermatopathology and skin disease.

KDL is not responsible for the availability or content of these external sites, nor does KDL endorse or guarantee the products, services or information described or offered at these other internet sites.

American Porphyria Foundation
American Skin Association, Inc.
BCCNS Life Support Network
Ehlers Danlos National Foundation
Dystrophic Epidermolysis Bullosa Research Association of America (DebRA)
Foundation for Ichthyosis and Related Skin Types (F.I.R.S.T)
Inflammatory Skin Disease Institute (email)
Lupus Foundation of America, Inc.
Mycosis Fungoides Foundation
National Alopecia Areata Foundation
National Association for Pseudoxanthoma Elasticum
The National Cancer Institute (Melanoma Link)
National Eczema Association for Science and Education (N.E.A.S.E)

National Foundation for Ectodermal Dysplasias
National Marfan Foundation
National Pemphigus Foundation
National Psoriasis Foundation
National Tuberous Sclerosis Association
National Vitiligo Foundation
National Vulvodynia Association
Nevus Outreach, Inc.
PXE International, Inc.
Scleroderma Foundation
Scleroderma Research Foundation
Sjogren’s Syndrome Foundation
Skin Cancer Foundation
Sturge-Weber Foundation
Tuberous Sclerosis Alliance
Xeroderma Pigmentosum Society

News and Events

Cancer survivors may be at higher risk of developing Melanoma. Read report

FDA approves Erivedge, the first drug to treat advanced basal cell carcinoma. Story

Diagnostic Update

KDL now providing FDA-approved BRAF testing for all metastatic melanomas. More

Contact Us

800.772.0951
865.584.1933
clientservices@kdlpathology.com
facebook icon

Stay Connected

Receive the DermPath Update or hear the latest news from KDL Pathology.